New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 887590-25-2, name is tert-Butyl 3,4-dihydroquinoxaline-1(2H)-carboxylate, introducing its new discovery. Product Details of 887590-25-2
Disclosed are compounds having the structure of Formula I, or a pharmaceutically acceptable salt of any thereof: wherein: “Z” and R1 are defined herein, which compounds are believed suitable for use in selectively antagonizing the A2a receptors, for example, those found in high density in the basal ganglia. Such compounds and pharmaceutical formulations are believed to be useful in treatment or management of neurodegenerative diseases, for example, Parkinson’s disease, or movement disorders arising from use of certain medications used in the treatment or management of Parkinson’s disease.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Product Details of 887590-25-2, you can also check out more blogs about887590-25-2
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1867 | ChemSpider